Artikel mit Open-Access-Mandaten - Aikaterini (Katerina) BerdiakiWeitere Informationen
Nicht verfügbar: 1
IGF-I regulates HT1080 fibrosarcoma cell migration through a syndecan-2/Erk/ezrin signaling axis
M Mytilinaiou, D Nikitovic, A Berdiaki, A Papoutsidakis, DJ Papachristou, ...
Experimental Cell Research 361 (1), 9-18, 2017
Mandate: US National Institutes of Health
Verfügbar: 6
Hyaluronan and reactive oxygen species signaling—novel cues from the matrix?
A Berdiaki, M Neagu, I Spyridaki, A Kuskov, S Perez, D Nikitovic
Antioxidants 12 (4), 824, 2023
Mandate: European Commission
Lumican in carcinogenesis—Revisited
EM Giatagana, A Berdiaki, A Tsatsakis, GN Tzanakakis, D Nikitovic
Biomolecules 11 (9), 1319, 2021
Mandate: European Commission
Glycosaminoglycans: Carriers and targets for tailored anti-cancer therapy
A Berdiaki, M Neagu, EM Giatagana, A Kuskov, AM Tsatsakis, ...
Biomolecules 11 (3), 395, 2021
Mandate: European Commission
Biglycan interacts with type I insulin-like receptor (IGF-IR) signaling pathway to regulate osteosarcoma cell growth and response to chemotherapy
EM Giatagana, A Berdiaki, M Gaardløs, SA Samsonov, GN Tzanakakis, ...
Cancers 14 (5), 1196, 2022
Mandate: European Commission, Narodowe Centrum Nauki
Rapamycin-induced autophagy in osteosarcoma cells is mediated via the biglycan/Wnt/β-catenin signaling axis
EM Giatagana, A Berdiaki, M Gaardløs, AM Tsatsakis, SA Samsonov, ...
American Journal of Physiology-Cell Physiology 323 (6), C1740-C1756, 2022
Mandate: Narodowe Centrum Nauki
Lumican in Carcinogenesis—Revisited. Biomolecules 2021, 11, 1319
EM Giatagana, A Berdiaki, A Tsatsakis, GN Tzanakakis, D Nikitovic
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
Mandate: European Commission
Angaben zur Publikation und Finanzierung werden automatisch von einem Computerprogramm ermittelt